P-glycoprotein polymorphism in hypo- and hyper-thyroidism patients

Molecular Biology Reports

Volumn 35, Issue 4, 2008, Pages 693-698

  Turgut, Günfer ^a   Baştemir, Mehmet ^a   Turgut, Sebahat ^a   Akın, Fulya ^a   Kursunluoglu, Raziye ^a   Kaptanoğlu, Bünyamin ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

C3435T; Hyperthyroidism; Hypothyroidism; MDR1; P glycoprotein polymorphism

Indexed keywords

GLYCOPROTEIN P; LIOTHYRONINE; MULTIDRUG RESISTANCE PROTEIN 1; THYROGLOBULIN ANTIBODY; THYROID HORMONE; THYROID PEROXIDASE; THYROTROPIN;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DNA ISOLATION; DRUG DISTRIBUTION; ETHNIC GROUP; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GENE FREQUENCY; GENOTYPE; GRAVES DISEASE; HASHIMOTO DISEASE; HORMONE BLOOD LEVEL; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 57349138896     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-007-9142-y     Document Type: Article

References (36)

1. AH Schinkel 1997 The physiological function of drug-transporting P-glycoproteins Semin Cancer Biol 8 161 170
2. K Ueda Y Yamano N Kioka 1989 Detection of multidrug resistance (MDR1) gene RNA expression in human tumors by a sensitive ribonuclease protection assay Jpn J Cancer Res 80 1127 1132
3. KM Barnes B Dickstein GB Cutler 1996 Steroid treatment, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells Biochemistry 35 4820 4827
4. TR Pippert DR Umbenhauer 2001 The subpopulation of CF-1 mice deficient in P-glycoprotein contains a murine retroviral insertion in the mdr1a gene J Biochem Mol Toxicol 15 83 89
5. C Wandel RB Kim S Kajiji 1999 P-glycoprotein and cytochrome P-450 3A inhibition: dissociation of inhibitory potencies Cancer Res 59 3944 3948
6. EG Schuetz AH Schinkel MV Relling 1996 P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans Proc Natl Acad Sci USA 93 4001 4005
7. VV Rao JL Dahlheimer ME Bardgett 1999 Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier Proc Natl Acad Sci USA 96 3900 3905
8. S Hoffmeyer O Burk O von Richter 2000 Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo Proc Natl Acad Sci USA 97 3473 3478
9. AH Schinkel E Wagenaar CAAM Mol 1996 P-glycoprotein in the blood-brain barrier of mice influences the penetration on pharmacological activity of many drugs J Clin İnvest 97 2517 2524
10. F Thiebaut T Tsuruo H Hamada 1987 Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues Proc Natl Acad Sci USA 84 7735 7738
11. H Huai-Yun DT Secrest KS Mark 1998 Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells Biochem Biophys Res Commun 243 816 820
12. N Kioka J Tsubota Y Kakehi 1989 P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly 185 with an altered pattern of multidrug resistance Biochem Biophys Res Commun 162 224 231
13. I Cascorbi T Gerloff A Johne 2001 Frequency of single nucleotide polymorphisms in teh P-glycoprotein drug transporter MDR-1 gene in white subjects Clin Pharmacol Ther 69 169 174
14. P Borst AH Schinkel 1997 Genetic dissection of the function of mammalian P-glycoproteins Trends Genet 13 217 222
15. Borst P, Schinkel AH (1996) Mice with disrupted PGP genes. In: Gupta S, Tsuruo T (eds) Multidrug resistance in cancer cells. John Wiley & Sons, New York, pp 5-20
16. C Verstuyft M Schwab E Schaeffeler 2003 Digoxin pharmacokinetics and MDR1 genetic polymorphisms Eur J Clin Pharmacol 58 809 812
17. B Chowbay S Cumaraswamy YB Cheung 2003 Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients Pharmacogenetics 13 89 95
18. R Kerb AS Aynacioglu J Brockmoller 2001 The predictive value of MDR1, CYP2C9, and CUP2C19 polymorphisms for phenytoin plasma levels Pharmacogenomics J 1 204 210
19. A Kafka G Sauer C Jaeger 2003 Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer Int J Oncol 22 1117 1121
20. J Fellay C Marzolini E Meaden 2002 Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study Lancet 359 30 36
21. A Siddiqui R Kerb ME Weale 2003 Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1 N Engl J Med 348 1442 1448
22. H Zheng S Webber A Zeevi 2002 The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patients Hum Immunol 63 765 770
23. W Siegmund S Altmannsberger A Paneitz 2002 Effect of levothyroxine administration on intestinal P-glycoprotein expression: consequences for drug disposition Clin Pharmacol Ther 72 256 264
24. T Mitin LL Von Moltke MH Court 2004 Levothyroxine up-regulates P-glycoprotein independent of the pregnane X receptor Drug Metab Dispos 32 779 782
25. MJ Simmonds JM Heward J Carr-Smith 2006 Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves' disease J Clin Endocrinol Metab 91 1056 1061
26. N Kioka J Tsubota Y Kakehi 1989 P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly 185 with an altered pattern of multidrug resistance Biochem Biophys Res Commun 162 224 231
27. S Turgut G Turgut EÖ Atalay 2006 Genotype and allele frequency of human multidrug resistance (MDR1) gene C3435T polymorphism in Denizli province of Turkey Mol Biol Rep 33 295 300
28. S Turgut A Yaren R Kurşunluoǧlu 2007 The MDR1 C3435T polymorphism in patients with breast cancer Arch Med Res 38 539 544
29. FA Neves RR Cavalieri LA Simeoni 2002 Thyroid hormone export varies among primary cells and appears to differ from hormone uptake Endocrinology 143 476 483
30. AM Mitchell M Tom RH Mortimer 2005 Thyroid hormone export from cells: contribution of P-glycoprotein J Endocrinol 185 93 98
31. L Kragie 1996 Membrane iodothyronine transporters, Part II: review of protein biochemistry Endocr Res 22 95 119
32. T Abe T Suzuki M Unno 2002 Thyroid hormone transporters: recent advances Trends Endocrinol Metab 13 215 220
33. P O'Connor J Feely 1987 Clinical pharmacokinetics and endocrine disorders-therapeutic implications Clin Pharmacokinet 13 345 364
34. GM Shenfield 1981 Influence of thyroid dysfunction on drug pharmacokinetics Clin Pharmacokinet 6 275 297
35. RC Ribeiro RR Cavalieri N Lomri 1996 Thyroid hormone export regulates cellular hormone content and response J Biol Chem 271 17147 17151
36. RB Kim BF Leake EF Choo 2001 Identification of functionally variant MDR1 alleles among European Americans and African Americans Clin Pharmacol Ther 70 189 199